胸科加速康复外科项目的五年持续影响
该研究在2015至2021年间前瞻性分析了1079例择期胸膜、肺或纵隔手术患者,比较加速康复项目(ERP)实施前后(2015年 vs 2016年5月1日至2021年12月31日)按切口类型(VATS或开胸)分组的结局。结果显示ERP-开胸组每例中位住院时间减少1.5天,ERP-VATS组减少1天;两组中位术后吗啡当量及总住院费用均显著下降(P < .001),术后房颤和尿潴留发生率在两个亚组中均降低。作者认为胸科ERP具有可持续性,可改善患者结局、减少阿片类药物使用并降低住院费用,有潜力成为标准治疗。
要点
- ERP-开胸组每例中位住院时间减少1.5天,ERP-VATS组减少1天。
- 中位术后吗啡当量:ERP-开胸组125 vs 45 mg,ERP-VATS组84 vs 23 mg(P < .001)。
- 总住院费用:ERP-开胸组$32,118 vs $23,775,ERP-VATS组$17,367 vs $11,560(P < .001)。
核心结论
- 胸科ERP具有可持续性,已证明可改善患者结局、减少阿片类药物使用并降低住院费用,有潜力成为标准治疗。
研究设计与样本
- 前瞻性分析2015年至2021年在本机构接受择期胸膜、肺或纵隔手术的患者,按切口分为VATS或开胸,比较ERP实施前(2015年)与实施后(2016年5月1日至2021年12月31日)的结局。
- 队列共1079例,ERP前时代n=224(21%),ERP时代n=855(79%)。
- ERP方案于2016年5月1日启动,包括术前教育、碳水化合物负荷、阿片类药物节约型镇痛、限制性液体管理、保护性通气和早期下床活动。
主要发现
- ERP-开胸组每例中位住院时间减少1.5天,ERP-VATS组每例中位住院时间减少1天。
- 中位术后吗啡当量下降:ERP-开胸组125 vs 45 mg,ERP-VATS组84 vs 23 mg(P < .001)。
- 总住院费用下降:ERP-开胸组$32,118 vs $23,775,ERP-VATS组$17,367 vs $11,560(P < .001)。
- 住院期间中位总液体平衡显著下降。
- 术后房颤和尿潴留发生率在两个亚组中均降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our thoracic enhanced recovery program (ERP) decreased the use of postoperative morphine equivalents and hospital costs 1 year after implementation at our tertiary center. The sustainability and potential increasing benefit of this program were evaluated. METHODS: From 2015 to 2021, we prospectively analyzed the outcomes of patients who underwent elective pleural, pulmonary, or mediastinal operations at our institution. Patients were separated on the basis of the incision (video-assisted thoracoscopic surgery [VATS] or thoracotomy). The ERP protocol was initiated on May 1, 2016, and includes preoperative education, carbohydrate loading, opioid-sparing analgesia, conservative fluid management, protective ventilation, and early ambulation. Outcomes of patients before (2015, pre-VATS and pre-thoracotomy) and after (May 1, 2016, to December 31, 2021, ERP-VATS and ERP-thoracotomy) ERP implementation were compared. RESULTS: The cohort included 1079 patients (pre-ERP era, n = 224 [21%]; ERP era, n = 855 [79%]). There was a median reduction of 1.5 hospital days per patient for ERP-thoracotomy and 1 hospital day per patient for ERP-VATS. Median postoperative morphine equivalents decreased in both groups (125 vs 45 mg, in ERP-thoracotomy; 84 vs 23 mg, ERP-VATS; P < .001), as did total admission cost ($32,118 vs $23,775, ERP-thoracotomy; $17,367 vs $11,560, ERP-VATS; P < .001). Median total fluid balance during the hospital stay decreased significantly. Rates of postoperative atrial fibrillation and urinary retention decreased across both subgroups. CONCLUSIONS: ERP for thoracic surgery is sustainable and has been demonstrated to improve patient outcomes, to decrease opioid use, and to lower hospital costs. Therefore, it has the potential to become the standard of care.
引用
- Young AM, Viktorsson SA, Strobel RJ, et al. Five-Year Sustained Impact of a Thoracic Enhanced Recovery After Surgery Program. Ann Thorac Surg. 2023. PMID: 37923241. doi:10.1016/j.athoracsur.2023.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。